View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 21, 2018

Medtronic to buy Mazor Robotics under $1.64bn deal

Medtronic has signed a definitive merger agreement to acquire 100% of the outstanding ordinary shares of surgical systems developer Mazor Robotics for a total consideration of about $1.64bn.

Medtronic has signed a definitive merger agreement to acquire 100% of the outstanding ordinary shares of surgical systems developer Mazor Robotics for a total consideration of about $1.64bn.

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

The deal bolsters Medtronic’s footprint in the spine surgery technologies area, while allowing more exposure to Mazor’s core platform technology of robotic-assisted surgery (RAS) systems.

The Mazor X Robotic Guidance System and Renaissance Surgical-Guidance System are designed for accurate guidance during spine surgery procedures.

“The deal bolsters Medtronic’s footprint in the spine surgery technologies area, while allowing more exposure to Mazor’s core platform technology of robotic-assisted surgery (RAS) systems.”

Medtronic expects that its spine implants, navigation and intra-operative imaging technology in combination with Mazor’s RAS systems will deliver a fully-integrated procedural solution.

Medtronic Restorative Therapies Group executive vice-president and president Geoff Martha said: “We believe robotic-assisted procedures are the future of spine surgery, enhancing surgeons’ abilities to perform complex procedures with greater precision, consistency and control.

The acquisition of Mazor adds robotic-assisted guidance systems to our expanding portfolio of enabling technologies, and we intend to further cultivate Mazor’s legacy of innovation in surgical robotics with the site and team in Israel as a base for future growth.”

In May 2016, Medtronic and Mazor signed a multi-phased strategic and equity investment agreement.

The alliance was expanded later in August last year, when Medtronic agreed to be the exclusive worldwide distributor of the Mazor X system.

Mazor Robotics CEO Ori Hadomi said: “The Mazor team and product portfolio’s full integration into Medtronic will maximise our impact globally through Medtronic’s channels, advance our systems’ leadership position in the marketplace, and drive the realisation of our vision to heal through innovation.”

Subject to customary closing conditions and approvals, the transaction is scheduled to be completed in Medtronic’s third fiscal quarter ending 25 January 2019.

Related Companies

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network